-
Aug 6, 2025
As investors and industry watchers juggle the twin possibilities of pharmaceutical import tariffs and potential drug pricing reform under the Trump administration, Pfizer CEO Albert...
-
Aug 1, 2025
As pharmaceutical import tariffs take shape in Europe, President Donald Trump is rounding out the week by spotlighting another one of his biggest industry bugbears: drug pricing.
-
Jul 30, 2025
At long last, the Trump administration’s much-ballyhooed tariffs on pharmaceutical imports are materializing in a trade deal with the European Union. Still, as with previous...
-
Jul 28, 2025
Despite the setback, Roche—which markets Elevidys outside the U.S.—remains committed to finding a path forward for the one-time treatment in the EU.
-
May 2, 2025
Eli Lilly CEO Dave Ricks is joining a growing number of pharma chiefs calling for tax reform, not tariffs, to bolster U.S. investments.
-
Apr 28, 2025
After unveiling a new drug substance facility in North Carolina in December, Amgen is doubling down on expanding its U.S. production presence with plans for a major upgrade at its...